Home » MILLENIA HOPE GENERATES SECOND MMH MALAREX(TM) SALE
MILLENIA HOPE GENERATES SECOND MMH MALAREX(TM) SALE
August 16, 2005
Millenia Hope Inc., a Delaware Biopharma corporation (OTC Bulletin Board: MLHP; Berlin: MLF), today announced that it has sold 10,000 treatments of MMH Malarex(TM)/MMH 18(TM) to a private clinic in Mali. This sale is the initial order from a second contract that could also generate sales of 100,000 treatments over the next 12 months. Previously, on August 10, 2005, Millenia Hope announced its initial African sale of 25,000 treatments from a contract totaling 100,000 treatments spread over the following 12 months.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-15-2005/0004088310&EDATE=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct